Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

WAY-140288: a follow-up V2 antagonist and aquaretic agent from Wyeth-Ayerst

Aug. 28, 1998

Profile of VPA-985, Wyeth-Ayerst's aquaretic agent in clinical trials

Aug. 28, 1998

A-131701: a uroselective alpha-adrenergic agent for treatment of BPH

Aug. 27, 1998

GG-745: a 5alpha-reductase inhibitor with significant advantages over finasteride

Aug. 27, 1998

Antimuscarinic agent KRP-197 shows potential for treating incontinence

Aug. 24, 1998

HMR-4902 protects against acute renal failure in rats

Aug. 20, 1998

Kissei studies beta-adrenergic drug for use in patients with urolithiasis

Aug. 18, 1998

New compound for urinary incontinence poised to enter clinical testing at Recordati

Aug. 14, 1998

AH-9700, a promising centrally and peripherally acting treatment for incontinence

Aug. 13, 1998

OPC-51803, a vasopressin V2 agonist with potent antidiuretic activity in rats and dogs

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...